Data Generalizability, Data Transferability, and the Political Economy of Pharmacoeconomic Guidelines
Economic Evaluations Alongside Effectiveness Trials
Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program
Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index
The Value of Correcting Values: Influence and Importance of Correcting TTO Scores for Time Preference
Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses
Expanded HIV Screening in the United States: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact Analysis
Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico
Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada
Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
Mixed Treatment Comparison Meta-Analysis Evaluating the Relative Efficacy of Nucleos(t)ides for Treatment of Nucleos(t)ide-Naive Patients with Chronic Hepatitis B
International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)
How Is Evidence on Test Performance Synthesized for Economic Decision Models of Diagnostic Tests? A Systematic Appraisal of Health Technology Assessments in the UK Since 1997
Recent Trends and Geographic Patterns of the Burden of Disease Attributable to Smoking
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure
Network Meta-Analysis with Competing Risk Outcomes
Functional Impairment and Disability across Mood States in Bipolar Disorder
The Role of Observational Investigations in Comparative Effectiveness Research
Is Longer Waiting Time for Total Knee Replacement Associated with Health Outcomes and Medication Costs? Randomized Clinical Trial
Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D
Predicting Time Trade-Off Health State Valuations of Adolescents in Four Pacific Countries Using the Assessment of Quality-of-Life (AQoL-6D) Instrument
What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?
Estimating the Effect of Medication Adherence on Health Outcomes among Patients with Type 2 Diabetes—An Application of Marginal Structural Models
Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?
Reviewer Acknowledgment
Erratum